| 1 |
33665638 | Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients. | 2021 Feb 16 |
2 |
| 2 |
31645049 | The Dopamine D2 Receptor Contributes to the Spheroid Formation Behavior of U87 Glioblastoma Cells. | 2020 |
2 |
| 3 |
30816566 | Dopamine receptor antagonists induce differentiation of PC-3 human prostate cancer cell-derived cancer stem cell-like cells. | 2019 May |
1 |
| 4 |
31822725 | Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells. | 2019 Dec 10 |
2 |
| 5 |
30093531 | A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia. | 2018 Aug 14 |
3 |
| 6 |
30131338 | Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2. | 2018 Oct 12 |
2 |
| 7 |
28454238 | Dopamine receptor D2 is correlated with gastric cancer prognosis. | 2017 Mar |
2 |
| 8 |
28649130 | Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer. | 2017 Sep |
1 |
| 9 |
27398159 | The important application of thioridazine in the endometrial cancer. | 2016 |
1 |
| 10 |
25832589 | Dopamine D2 receptor blocker thioridazine induces cell death in human uterine cervical carcinoma cell line SiHa. | 2015 Aug |
6 |
| 11 |
8302284 | Inhibition of P-type and N-type calcium channels by dopamine receptor antagonists. | 1994 Jan |
1 |